Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.33 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.33 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.33 |
| ▸ | MAP3K7 | O43318 | 3/20 | 0.32 |
| ▸ | TAB1 | Q15750 | 3/20 | 0.32 |
| ▸ | NAMPT | P43490 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
| ▸ | PPARG | P37231 | 1/20 | 0.32 |
| ▸ | PPARA | Q07869 | 1/20 | 0.32 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.31 |
| ▸ | TK1 | P04183 | 1/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
| ▸ | TYMS | P04818 | 3/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25387199 | 0.90 | TAAR1 (0.36) | PPARGPPARAHCAR2TK1TYMS | |
| SCHEMBL25390339 | 0.85 | MAPT (0.33) | MEN1NPC1RAB9AKMT2ATK1 | |
| SCHEMBL25388131 | 0.82 | HPGD (0.35) | MEN1NPC1RAB9AKMT2ATYMS | |
| SCHEMBL17652009 | 0.79 | KMT2A (0.35) | MEN1RAB9AKMT2ATYMS | |
| SCHEMBL25815335 | 0.73 | KCNA5 (0.36) | MEN1KMT2ARECQL | |
| SCHEMBL19253836 | 0.72 | TYMS (0.34) | RAB9ATYMS | |
| SCHEMBL25390380 | 0.71 | TYMS (0.43) | TYMS | |
| SCHEMBL17652022 | 0.71 | CHUK (0.43) | TYMS | |
| SCHEMBL19253834 | 0.70 | MPO (0.39) | TYMS | |
| SCHEMBL17652035 | 0.67 | LMNA (0.35) | MEN1KMT2ATYMS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4188553-B1 | COMPOUNDS | PROVOST FELLOWS FOUND SCHOLARS & OTHER MEMBERS BOARD COLLEGE HOLY & UND (IE) | 2024-05-08 | — | — | EP | disclosed |
| CN-116783197-A | Compounds of formula (I) | 都柏林圣三一学院教务长、研究员、基金会学者及董事会其他成员 | 2023-09-19 | — | — | CN | disclosed |
| US-20230286987-A1 | COMPOUNDS | THE PROVOST, FELLOWS, FOUNDATION SCHOLARS, AND THE OTHER MEMBERS OF BOARD, OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH, NEAR DUBLIN (IE) | 2023-09-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230286987-A1 | COMPOUNDS | HAX1, NHERF1, CXCR1 | MEN1 887/4885NPC1 65/4885RAB9A 1109/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.